Tausight offers an AI-powered PHI Security Intelligence platform that automates the identification and classification of electronic protected health information to help healthcare organizations protect patient data. Earlier this year the company launched an expanded version of the platform to cover more sensitive healthcare data categories and address additional customer use cases. The firm says the expansion will allow it to serve new healthcare market segments. Tausight was founded in 2018 and is led by healthcare visionary Frank Nydam; David Ting is a founder and healthcare security pioneer. The company raised an additional $6M in financing to accelerate market presence and customer growth. Tausight plans to continue investing in its patented AI technology with the new funds. Tausight develops a healthcare-specific security solution that discovers and helps secure protected health information (PHI) by exposing hidden vulnerabilities in clinical workflows. Its product analyzes in real time how patient data is stored, used, and transmitted in clinical environments to help CIOs, CISOs, and IT teams proactively address risks. Founder and CTO David Ting — cofounder and former CTO of Imprivata and a former appointee to the U.S. Department of Health and Human Services Health Care Industry Cybersecurity Task Force — leads the company. Tausight targets gaps created by healthcare decentralization, virtual care, and cloud-first strategies that the company says increase PHI exposure. The company will use the Series A proceeds to expand its go-to-market team and further build out its healthcare-specific solution. No operating metrics or revenue figures were disclosed in the announcement.

Total raised

$26M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2023